EUVIMEDEUVIMED entdecken
Crossref

Genetically Engineered Bacteria as A Living Bioreactor for Monitoring and Elevating Hypoxia‐Activated Prodrug Tumor Therapy

Hongwei Zhang, Linfu Chen, Qian Chen, Qiufang Chen, Jun Zhou iD

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202402272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Hongwei Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China. Hauptthemen laut MEDLINE: Prodrugs, Escherichia coli, Tirapazamine, Hydrogels. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, the Natural Science Research Project for Universities of Anhui Province, the Research Fund of Anhui Institute of translational medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tirapazamine (TPZ), an antitumor prodrug, can be activated in hypoxic environment. It specifically targets the hypoxic microenvironment of tumors and produces toxic free radicals. However, due to the tumor is not completely hypoxic, TPZ often fails to effectively treat the entire tumor tissue, resulting in suboptimal therapeutic outcomes. Herein, a low pathogenic Escherichia coli TOP10 is utilized to selectively colonize tumor tissues, disrupt blood vessels, and induce thrombus formation, leading to the expansion of hypoxic region and improving the therapeutic effect of TPZ. Additionally, a thermosensitive hydrogel is constructed by Pluronic F‐127 (F127), which undergoes gelation in situ at the tumor site, resulting in sustained release of TPZ. To monitor the therapeutic process, it is genetically modified TOP10 by integrating the bioluminescent system luxCDABE (TOP10‐Lux). The bioluminescent signal is associated with tumor hypoxia enhancement and thrombus formation, which is beneficial for therapeutic monitoring with bioluminescence imaging. In the murine colon cancer model, the TOP10‐Lux combined with TPZ‐loaded F127 hydrogel effectively suppressed tumor growth, and the treatment process is efficiently monitored. Together, this work employs genetically modified TOP10‐Lux to enhance the therapeutic efficacy of TPZ and monitor the treatment process, providing an effective strategy for bacteria‐based tumor‐targeted chemotherapy and treatment monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsEscherichia coliTirapazamineHydrogelsAnimalsMiceCell Line, TumorBioreactorsColonic NeoplasmsHumansPoloxamerMice, Inbred BALB CGenetic EngineeringAntineoplastic AgentsTumor Microenvironment

Stichwörter der Autor:innen

genetically engineered bacteriahypoxia‐activated prodrugsynthetic biologythermosensitive hydrogelthrombustreatment monitoring

Substanzen

ProdrugsTirapazamineHydrogelsPoloxamerAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
  • Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Suzhou, 215123, China.
  • Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
  • School of Pharmacy, Anhui Medical University, Hefei, 230032, China.
  • Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.

ORCID-Profile: Jun Zhou

Förderung

  • National Natural Science Foundation of China
  • the Natural Science Research Project for Universities of Anhui Province
  • the Research Fund of Anhui Institute of translational medicine

Zitieren

APA

Zhang, H., Chen, L., Chen, Q., Chen, Q., & Zhou, J. (2025). Genetically Engineered Bacteria as A Living Bioreactor for Monitoring and Elevating Hypoxia‐Activated Prodrug Tumor Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402272

Vancouver

Zhang H, Chen L, Chen Q, Chen Q, Zhou J. Genetically Engineered Bacteria as A Living Bioreactor for Monitoring and Elevating Hypoxia‐Activated Prodrug Tumor Therapy. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202402272

BibTeX
@article{Zhang2025,
  author = {Zhang, Hongwei and Chen, Linfu and Chen, Qian and Chen, Qiufang and Zhou, Jun},
  title = {Genetically Engineered Bacteria as A Living Bioreactor for Monitoring and Elevating Hypoxia‐Activated Prodrug Tumor Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202402272}
}
Kostenlos starten →